OLO BREAKING INVESTIGATION: BFA Law is Investigating Olo Inc.'s Board for Breaching its Fiduciary Duties in Connection with the $10.25 Merger Price - Contact BFA Law — Neutral
OLO GlobeNewsWire — July 10, 2025NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Olo Inc. (NYSE: OLO), its board of directors, its executive officers, and founder and current CEO Noah H. Glass for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of Olo to Thoma Bravo Discover Fund IV, L.P.

While the broader market, led by the technology sector and many of the Magnificent Seven members, continues to hit new highs, GOOGL has remained one of the few laggards.

Business class+? Delta says segmentation is coming to high-end cabins — Neutral
DAL CNBC — July 10, 2025Delta is studying changes to its premium-cabin offerings, similar to what airlines have done in coach.

The highly anticipated 'duration trade' in long bonds like TLT has underperformed despite the Fed lowering rates by 100bp since their peak. TLT's price hasn't rebounded as expected because its yield hasn't shifted enough, even though short-term rates have declined. In fact, YoY, long rates have risen! I've consistently favored the short end of the curve, particularly the SGOV ETF, which has provided reliable returns during this period. I continue to endorse it moving forward.

KLG Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of WK Kellogg Co. to Ferrero Group — Neutral
KLG GlobeNewsWire — July 10, 2025MONSEY, N.Y., July 10, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of WK Kellogg Co. (NYSE: KLG) (“Kellogg”) to Ferrero Group for $23.00 per share in cash.

Aspen: Navigating Profit In A Hardening Insurance Market — Positive
AHL Seeking Alpha — July 10, 2025Aspen has demonstrated strong underwriting profitability and value creation despite industry headwinds, supported by a hardening insurance market and disciplined capital allocation. The company's integrated 'One Aspen' approach and ACM platform differentiate it, enabling bespoke risk solutions and stable, growing fee income from third-party capital. Aspen continues to generate economic profit with solid free cash flow and an attractive valuation, with the market pricing in conservative growth assumptions.

Otis Worldwide Q2 Preview: Anticipating Weak Equipment Sales — Negative
OTIS Seeking Alpha — July 10, 2025I reiterate a Sell rating on Otis Worldwide Corporation, with a fair value of $82 per share, due to a persistently weak growth outlook. Otis faces ongoing headwinds from sluggish China real estate and global housing markets, resulting in declining new equipment sales. Management's optimism on China's recovery appears premature, especially amid continued property price declines and U.S.-China tariff uncertainties.

Aurora Innovation CEO on Self-Driving Trucks, Working With Nvidia — Neutral
AUR NVDA Bloomberg Markets and Finance — July 10, 2025Aurora Innovation CEO Chris Urmson discusses the company's autonomous trucking service, the regulatory environment and partnership with Nvidia. He speaks with Ed Ludlow at the Sun Valley conference.

Apple, Visa and Mastercard Antitrust Lawsuit Tossed by Federal Judge — Positive
AAPL MA V PYMNTS — July 10, 2025Apple, Visa and Mastercard reportedly won a legal victory in an antitrust lawsuit. The tech giant and the two payment firms convinced a federal judge to dismiss the lawsuit accusing them of colluding to stifle competition, Reuters reported Thursday (July 10).

Rhythm: Oral Bivamelagon Data Signals Dominance In Hypothalamic Obesity Market — Positive
RYTM Seeking Alpha — July 10, 2025Rhythm Pharmaceuticals, Inc.'s IMCIVREE and new oral MC4R agonist, bivamelagon, show strong efficacy in rare obesity disorders, especially hypothalamic obesity (HO). HO represents a blockbuster market opportunity with minimal competition, as MC4R agonists address the root cause, unlike GLP-1s. Pipeline expansion, including oral and weekly MC4R agonists, positions Rhythm for long-term market dominance in rare obesity beyond 2040.

CNC BREAKING CLASS ACTION: Centene Corporation has been Sued for Securities Fraud; Investors with Losses are Notified to Contact BFA Law by September 8 Court Deadline (NYSE:CNC) — Neutral
CNC GlobeNewsWire — July 10, 2025NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Centene Corporation (NYSE: CNC) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Centene, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/centene-corporation-class-action-lawsuit.

DALN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DallasNews Corporation Is Fair to Shareholders — Neutral
DALN Business Wire — July 10, 2025NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of DallasNews Corporation (NASDAQ: DALN) to Hearst for $14.00 in cash per share is fair to DallasNews shareholders. Halper Sadeh encourages DallasNews shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether DallasNews and.

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules — Neutral
ICU GlobeNewsWire — July 10, 2025DENVER, July 10, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, today announced it has entered into a definitive agreement for the issuance and sale of an aggregate of 5,242,464 shares of its common stock (or common stock equivalents in lieu thereof) at a purchase price of $0.763 per share of common stock (or per common stock equivalent in lieu thereof), in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, …

How to play Apple shares and big bank earnings as the stock market hits another record — Neutral
AAPL Market Watch — July 10, 2025U.S. stocks are overbought — but overbought does not mean sell.

EQT Corp (NYSE:EQT) is down 1.5% at $54.06 at last glance, extending a pullback from its June 23, record high of $61.02.

Methode Electronics, Inc. (MEI) Q4 2025 Earnings Call Transcript — Neutral
MEI Seeking Alpha — July 10, 2025Methode Electronics, Inc. (NYSE:MEI ) Q4 2025 Earnings Conference Call July 10, 2025 11:00 AM ET Company Participants Jonathan B. DeGaynor - President, CEO & Director Laura M.

STAR OF THE SEAS OFFICIALLY JOINS ROYAL CARIBBEAN AS THE NEXT ICONIC VACATION — Neutral
RCL PRNewsWire — July 10, 2025The ultimate family vacation has completed construction and is one step closer to its August debut in Port Canaveral (Orlando), Florida MIAMI , July 10, 2025 /PRNewswire/ -- Royal Caribbean kicked off the countdown to a new era of family vacations, officially welcoming Star of the Seas * into the family. After nearly two years of construction at the Meyer Turku shipyard in Turku, Finland , the keys to the next revolutionary Icon Class ship were officially handed over to Royal Caribbean just a few weeks ahead of its August debut in Port Canaveral (Orlando), Florida.

Wells Fargo reportedly sees signs of an economic slowdown, with job creation slowing and inflation expected to rise.
